Salvage inotuzumab ozogamicin improves ALL outcomes
Compared with standard chemotherapy, treatment with inotuzumab ozogamicin increases the rate of complete remission and allows a higher proportion of patients with relapsed or refractory acute lymphoblastic leukaemia to subsequently receive stem-cell transplantation, research suggests.
Source: MedWire News - Category: Consumer Health News Tags: Leukaemia Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Chemotherapy | Health | Leukemia | Stem Cell Therapy | Stem Cells | Transplants